AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

In a large Norwegian study, a commercial AI tool analyzed routine mammograms and identified women at elevated risk of ...

The system can be applied immediately to clinical practice, Larry Norton, MD, a breast cancer specialist at Memorial Sloan ...

Under the partnership, GE HealthCare will serve as the technology partner, and TMC will be the clinical oncology partner.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Researchers have been working toward using the gut microbiome as a clinical target for screening for colorectal cancer. This ...

Tata Memorial Centre partners with GE HealthCare to advance cancer care in India with AI-driven solutions and innovative ...